Jugpal S. Arneja

Jugpal S. Arneja

Auto-generated profile, based on publicly available information

Jugpal S. Arneja

Division of Plastic Surgery, BC Children’s Hospital

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
JAJugpal S. Arneja
Jugpal S. Arneja
AGArun K. Gosain
Arun K. Gosain
After studying this article, the participant should be able to: 1. Define what is meant by a giant congenital melanocytic nevus and understand its histologic properties. 2. Know the natural history and potential complications associated with a giant congenital melanocytic nevus. 3. Outline the nonsurgical and surgical options available to treat a giant congenital melanocytic nevus. Giant congenital melanocytic nevi are rare lesions with a propensity to degenerate to malignant melanoma. Certain lesions also may be associated with neurocutaneous melanosis, which can on occasion be symptomatic. Appropriate investigations include a screening magnetic resonance imaging scan, neurologic evaluation, and serial clinical observations for the development of cutaneous melanoma. A variety of nonsurgical and surgical options are possible for the treatment of giant congenital melanocytic nevi. A MEDLINE search was performed to gather all pertinent articles from 1955 to 2005. Giant congenital melanocytic nevi are a difficult diagnostic and reconstructive challenge, requiring careful preoperative evaluation, staged surgical excision, and lifelong patient monitoring and follow-up. With proper treatment, patients can expect a decreased risk of melanoma, with the possibility for early detection and cure of melanoma, amelioration of symptoms, improved aesthetics and psychosocial sequelae, and maintenance of function. The plastic surgeon treating these challenging lesions must have a solid working knowledge of the disease’s histology, its natural history and complications, and the options for treatment.

1 April 2008 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
JAJugpal S. Arneja
Jugpal S. Arneja
AGArun K. Gosain
Arun K. Gosain
After studying this article, the participant should be able to: 1. Understand the nomenclature and classification system of vascular malformations. 2. Evaluate these patients diagnostically. 3. Outline the surgical and nonsurgical options for treating these lesions. Vascular anomalies can be classified into two unique groups—hemangiomas and vascular malformations—based on their endothelial properties. The present review focuses on vascular malformations rather than hemangiomas. The authors address capillary malformations, lymphatic malformations, venous malformations, and arteriovenous malformations. Diagnostic and therapeutic modalities are discussed with relevant case examples. A MEDLINE search was performed to gather all pertinent references. The physician treating these challenging lesions should ideally use a multidisciplinary team–based approach with multispecialty experience in diagnostic and therapeutic modalities for the management of vascular malformations.

1 July 2009 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
JAJugpal S. Arneja
Jugpal S. Arneja
AGArun K. Gosain
Arun K. Gosain
Giant congenital melanocytic nevi are rare lesions with the potential to regress into malignant melanoma and/or neurocutaneous melanosis. Appropriate investigations include a screening magnetic resonance imaging scan, neurologic evaluation, and serial clinical observations looking for the development of these complications. Numerous excisional and nonexcisional options have been described for the management of giant congenital melanocytic nevi. A MEDLINE search was performed to obtain all relevant citations. To successfully treat these complex lesions, the plastic surgeon must understand the disease process, the natural history and complications, and the options for treatment.

1 September 2005 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
JAJugpal S Arneja
Jugpal S Arneja
AGArun K Gosain
Arun K Gosain
Giant congenital melanocytic nevi (CMN) are rare, congenital, disfiguring lesions with a risk of degeneration to malignant melanoma. Giant CMN are associated with an increased risk of malignant degeneration. In a minority of cases, patients with giant CMN may have associated neurocutaneous melanosis with leptomeningeal involvement. Giant CMN of the trunk pose difficult diagnostic and reconstructive problems requiring complex multistage treatment. For high-risk cases, diagnostic evaluation in the form of neuro-imaging is an essential component of the planning phase. Although nonsurgical options for the treatment of giant CMN have been advocated, these modalities may decrease the burden of nevus cells but do not result in complete removal of these cells. The ability to monitor nevus cells that remain after nonsurgical management of giant CMN remains questionable. These nonsurgical options include dermabrasion, laser ablation, and chemical peel. In contrast, direct excision of the nevus is the mainstay of treatment of nonsurgical management of giant CMN. There are numerous surgical options to resurface the resultant cutaneous defect after excision of the nevus. The simplest of these options consists of serial excision and direct closure of the defect in stages. However, if the defect cannot be closed by direct cutaneous advancement, other options for wound resurfacing include split- or full-thickness skin graft, tissue expansion, and free tissue transfer. Tissue expansion should be viewed as a category of treatment options because expanders can be used to create an expanded full-thickness skin graft, local expanded flaps adjacent to the lesion, or expansion of a free tissue donor site. Given the diversity of reconstructive options that use tissue expansion, these techniques have evolved as the primary treatment method for giant CMN of the trunk. The authors outline an approach to the evaluation of giant CMN of the trunk, review the risks of melanoma and of neurocutaneous melanosis, describe their preferred treatment regimen, and offer a treatment algorithm for giant CMN of the trunk.

1 February 2017 in Plastic Surgery
Verified
Journal Article
Closed access
WLWai-Yee Li
Wai-Yee Li
APAlana Poon
Alana Poon
DCDouglas Courtemanche
Douglas Courtemanche
CVCynthia Verchere
Cynthia Verchere
SRSandra Robertson
Sandra Robertson
JAJugpal S. Arneja
Jugpal S. Arneja
Background: Pierre Robin sequence (PRS) is a triad of micrognathia, glossoptosis, and respiratory distress. There is no standard clinical classification used in the management of neonatal airway in patients with PRS. The goal of our study was to review the presentation and management of patients with PRS and formulate a clinical grading system and treatment algorithm. Methods: A 10-year retrospective review of all neonates diagnosed with PRS was performed after obtaining institutional ethics approval. Patients were identified using our cleft lip and palate program database. Inclusion criteria were 2 of the following 3 clinical features—glossoptosis, retrognathia, or airway obstruction. We collected demographic data, clinical information (coexisting airway morbidity, maxillary-mandibular discrepancy, type of intervention used, complications, and outcomes (feeding, length of stay, and airway status) during the first year of life. Results: Sixty-three patients met our inclusion criteria. Of these, 55 (87%) had cleft palate and 17 (27%) were syndromic. Forty-eight (76%) patients were managed by prone positioning. Of the 15 surgically managed patients, the initial procedure was floor of mouth release in 7, mandibular distraction osteogenesis (MDO) in 4, and tongue-lip adhesion in 4. Five patients with coexisting airway morbidity needed a second surgery; 2 had MDO and 3 tracheostomies (one patient was later decannulated). Seven (47%) of the surgically managed patients required a gastrostomy tube. Conclusion: At present, there is no consensus on neonatal airway management in infants with PRS. From our review of 63 patients with PRS, we hereby propose a simple 4-point classification system and treatment algorithm, based on clinical features.

21 November 2017 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
MFMark Felton
Mark Felton
JLJong Wook Lee
Jong Wook Lee
DBDarius D. Balumuka
Darius D. Balumuka
JAJugpal S. Arneja
Jugpal S. Arneja
NCNeil K. Chadha
Neil K. Chadha